Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News MacroGenics Inc MGNX

Healthcare Biotechnology
MacroGenics, Inc. is a biopharmaceutical company focused on developing and commercializing monoclonal antibody-based therapeutics for the treatment of cancer. It generates its pipeline of product candidates primarily from its suite of antibody-based technology platforms, which have applicability across broad therapeutic domains. It is developing product candidates that target various tumor... see more

Recent & Breaking News (NDAQ:MGNX)

MacroGenics, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before September 24, 2024 to Discuss Your Rights - MGNX

Accesswire September 9, 2024

Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of MacroGenics, Inc. (MGNX) Shareholders

Accesswire September 9, 2024

MacroGenics Inc Is Being Sued For Violating Securities Laws And Impacted Shareholders Should Reach Out To The Schall Law Firm

Accesswire September 9, 2024

The Gross Law Firm Reminds MacroGenics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 24, 2024 - MGNX

PR Newswire September 9, 2024

Class Action Filed Against MacroGenics, Inc. (MGNX) Seeking Recovery for Investors - Contact Levi & Korsinsky

Accesswire September 9, 2024

MGNX STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that MacroGenics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

Accesswire September 9, 2024

MGNX CLASS ACTION FILED: Kessler Topaz Meltzer & Check, LLP Reminds Investors - A Securities Fraud Class Action Lawsuit Has Been Filed Against MacroGenics, Inc.

Accesswire September 9, 2024

Class Action Filed Against MacroGenics, Inc. (MGNX) - September 24, 2024 Deadline to Join - Contact Levi & Korsinsky

Accesswire September 9, 2024

MGNX Investors Have Opportunity to Lead MacroGenics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

PR Newswire September 9, 2024

MacroGenics Announces TAMARACK Phase 2 Data Presentation at ESMO Congress 2024

GlobeNewswire September 8, 2024

Shareholders that lost money on MacroGenics, Inc.(MGNX) should contact Levi & Korsinsky about pending Class Action - MGNX

Accesswire September 8, 2024

Class Action Filed Against MacroGenics, Inc. (MGNX) Seeking Recovery for Investors - Contact Levi & Korsinsky

Accesswire September 8, 2024

MGNX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that MacroGenics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

Accesswire September 8, 2024

Class Action Filed Against MacroGenics, Inc. (MGNX) - September 24, 2024 Deadline to Join - Contact Levi & Korsinsky

Accesswire September 8, 2024

SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of MacroGenics

Newsfile September 8, 2024

Shareholders that lost money on MacroGenics, Inc.(MGNX) should contact Levi & Korsinsky about pending Class Action - MGNX

Accesswire September 7, 2024

ROSEN, A LEADING LAW FIRM, Encourages MacroGenics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - MGNX

Newsfile September 7, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against MacroGenics, Inc. - MGNX

Accesswire September 7, 2024

MacroGenics, Inc. Investors Reminder: Kessler Topaz Meltzer & Check, LLP Reminds MacroGenics, Inc. Shareholders of Deadline in Securities Fraud Class Action Lawsuit

PR Newswire September 7, 2024

A Securities Fraud Case Has Been Filed Against MacroGenics, Inc. And The Schall Law Firm Encourages Investor Participation

Accesswire September 7, 2024